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Modeling the effect of the COVID-19
pandemic on Azithromycin prescription 




To develop a time series forecast model that demonstrates the effect of the pandemic on 
Azithromycin prescription and use in the UK
The forecast model is trained with the antibiotic pre-covid dataset, and the model predicts 
what the prescription data would have been without the pandemic influence during the 
pandemic months(EXPECTED TREND)
The predicted expected trend is then compared with the ACTUAL TREND of Azithromycin 
prescription recorded in the course of the pandemic, to observe the effect of the 
pandemic.
Choice of Antibiotic
• Azithromycin is a broad spectrum macrolide used for chronic 
inflammatory lung disease due to their immunomodulatory 
effects, decreasing production of pro-inflammatory cytokines 
and inhibiting neutrophil activation.
• There is no justifiable preclinical or clinical evidence to 
suggest that the benefits of azithromycin for COVID-19 
outweigh the risks of treatment or has antiviral activity 
against betacoronaviruses.
Project Timeline
• 31st December, 2019 – Novel virus identified in Wuhan, China
• 31st January, 2020 – First reported COVID-19 case in the United Kingdom
• 23rd March, 2020 – The United Kingdom went into lockdown
• March 2020 – Month with highest Azithromycin prescription to General Practice, UK 
(77856 Azithromycin items)
• 27th May, 2020 – WHO announced Azithromycin not effective, and should not be 
administered for treatment or COVID-19 prophylaxis






Patient Population Linear Regression and  correlation
Forecast using Time series decomposition
Peculiarity of the Time series 
decomposition:
Uses 
I - Trend and 
II - Seasonality 
of the trained dataset to model a 
forecast for the predictive values
Azithromycin Prescription Forecast with prediction intervals
Dark Green band – 80% Prediction Interval
Light Green band – 95% Prediction Interval

Control Antibiotic - Metronidazole
Metronidazole had no significant pandemic 
prescription influence
Metronidazole has a downward trend across 
the years





Point Forecast cut across actual trend 3 times, indicative of a 
relatively weak Actual vs Expected prediction similarity, 
hence high divergence due to the pandemic, with a constant 
forecast error factor
Control – Metronidazole
Point Forecast cut across actual trend 7 times, indicative of a 
relatively strong Actual vs Expected prediction similarity, 
hence low divergence due to the pandemic, with a constant 
forecast error factor
Conclusion
• Azithromycin prescription spike in March and April significantly influenced by :
– Unjustified, non-randomized, uncontrolled clinical trials
– Increased remote/telephone consultations
– Misinformation
• Model differences show spike in March and April to be significant: 10.23% to 12.15% increase in 
actual than expected
– Initial exposure of general practice patients to high Azithromycin dispensation significant to 
cause consequent antimicrobial resistant Helicobacter sp., Staphylococcus aureus, Streptococcus 
pneumoniae, Streptococcus pyogenes microbes in the UK.
• However, model also shows that consequent months into the pandemic had lower than expected 
prescription values
– Hence, there was also significant decrease in Azithromycin use after obvious bland effect in 
treatment and prophylaxis 
Further probes
• Look at more control antibiotics to observe average divergence of 
forecast modeling from actual values
• Alongside Time series decomposition forecast modeling, use other 
advance modeling methods to increase accuracy of forecast.
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